Bridgewater Advisors Inc. Buys 21,218 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Bridgewater Advisors Inc. raised its holdings in Aspen Aerogels, Inc. (NYSE:ASPN) by 37.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 77,357 shares of the construction company’s stock after acquiring an additional 21,218 shares during the period. Bridgewater Advisors Inc. owned about 0.10% of Aspen Aerogels worth $2,142,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets boosted its position in Aspen Aerogels by 85.2% during the first quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock valued at $452,000 after purchasing an additional 11,823 shares during the last quarter. GSA Capital Partners LLP bought a new stake in Aspen Aerogels in the first quarter valued at approximately $1,181,000. Oppenheimer & Co. Inc. bought a new stake in Aspen Aerogels in the first quarter valued at approximately $388,000. Swiss National Bank raised its stake in Aspen Aerogels by 16.2% in the first quarter. Swiss National Bank now owns 120,500 shares of the construction company’s stock valued at $2,121,000 after buying an additional 16,800 shares during the period. Finally, Vanguard Group Inc. raised its stake in Aspen Aerogels by 5.1% in the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after buying an additional 175,906 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

Aspen Aerogels Stock Down 9.0 %

Shares of NYSE:ASPN opened at $16.85 on Thursday. The firm has a market cap of $1.30 billion, a P/E ratio of -1,685.00 and a beta of 2.21. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. Aspen Aerogels, Inc. has a 12-month low of $8.76 and a 12-month high of $33.15. The business has a fifty day simple moving average of $23.58 and a 200 day simple moving average of $24.66.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. The firm had revenue of $117.80 million during the quarter, compared to analyst estimates of $101.99 million. During the same period last year, the company posted ($0.22) EPS. The business’s quarterly revenue was up 144.4% on a year-over-year basis. Analysts predict that Aspen Aerogels, Inc. will post 0.1 earnings per share for the current year.

Analysts Set New Price Targets

ASPN has been the topic of several research analyst reports. HC Wainwright restated a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Benchmark reiterated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a research note on Thursday, August 8th. TD Cowen increased their target price on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. Finally, Piper Sandler lowered their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.40.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.